NDC 10157-9409 - Blistex Baby Kanka
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 10157-9409
- Package NDCs from labels
- 10157-9409-1
- Manufacturer
- Blistex Inc.
- Effective date
- 2015-01-22
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Blistex Baby Kanka ® Gel | Blistex Inc. | 2015-01-22 | HUMAN OTC DRUG LABEL |
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 10157-9409-1 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-dd11-f424-e053-dadaa90a57ce | Blistex Baby Kanka ® Gel |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 10157-9409-1 | Blistex Baby Kanka | 10 g in 1 TUBE | GEL | 10 | 1 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 10157-9409 | BLISTEX BABY KANKA (BENZOCAINE) GEL [BLISTEX INC.] | 1 | 1 package rows | 20150129_b70ff808-43d3-4a14-867e-b56f9db9da87.zip |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| Benzocaine | ACTIVE INGREDIENT | U3RSY48JW5 | BLISTEX BABY KANKA (BENZOCAINE) GEL [BLISTEX INC.] | 1 | |
| Benzocaine | ACTIVE MOIETY | U3RSY48JW5 | BLISTEX BABY KANKA (BENZOCAINE) GEL [BLISTEX INC.] | 1 | |
| GLYCERIN | INACTIVE INGREDIENT | PDC6A3C0OX | BLISTEX BABY KANKA (BENZOCAINE) GEL [BLISTEX INC.] | 1 | |
| METHYLPARABEN | INACTIVE INGREDIENT | A2I8C7HI9T | BLISTEX BABY KANKA (BENZOCAINE) GEL [BLISTEX INC.] | 1 | |
| POLYETHYLENE GLYCOL 3350 | INACTIVE INGREDIENT | G2M7P15E5P | BLISTEX BABY KANKA (BENZOCAINE) GEL [BLISTEX INC.] | 1 | |
| POLYETHYLENE GLYCOL 400 | INACTIVE INGREDIENT | B697894SGQ | BLISTEX BABY KANKA (BENZOCAINE) GEL [BLISTEX INC.] | 1 | |
| PROPYLPARABEN | INACTIVE INGREDIENT | Z8IX2SC1OH | BLISTEX BABY KANKA (BENZOCAINE) GEL [BLISTEX INC.] | 1 | |
| SORBIC ACID | INACTIVE INGREDIENT | X045WJ989B | BLISTEX BABY KANKA (BENZOCAINE) GEL [BLISTEX INC.] | 1 | |
| SUCRALOSE | INACTIVE INGREDIENT | 96K6UQ3ZD4 | BLISTEX BABY KANKA (BENZOCAINE) GEL [BLISTEX INC.] | 1 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Antiseptic | BENZALKONIUM CHLORIDE, BENZOCAINE | JHK Inc | 0ac5d890-c262-4a30-9fd8-2de6cb0f7601 | 2024-04-25 | Warnings | U3RSY48JW5 |
| Quality Choice Oral Pain Relief | BENZOCAINE 20%, BENZALKONIUM CHLORIDE 1% | Quality Choice (CHAIN DRUG MARKETING ASSOCIATION) | 162702b4-4bf7-8868-e063-6294a90a5921 | 2024-04-15 | Warnings | U3RSY48JW5 |
| Visine Red Eye Hydrating Comfort Eye Drops | TETRAHYDROZOLINE HYDROCHLORIDE AND POLYETHYLENE GLYCOL 400 | Navajo Manufacturing Company Inc. | a70751ff-a313-49a7-e053-2a95a90a5447 | 2024-04-15 | Warnings | B697894SGQ |
| Gelato Topical Anesthetic | BENZOCAINE | Mycone Dental Supply Co., Inc DBA Keystone Industries and Deepak Products Inc | 9991de96-99a1-42f0-9ddd-e530ca9ceab1 | 2024-04-11 | Warnings | U3RSY48JW5 |
| PREPARATION H Maximum Strength | GLYCERIN, PETROLATUM, PHENYLEPHRINE HCL, PRAMOXINE HCL | Haleon US Holdings LLC | 7cc03d2e-e708-589a-d9bb-58ebbda989c0 | 2024-04-05 | Warnings | PDC6A3C0OX |
| Insect Sting Relief Pad TOALLITAS PARA PICADURAS DE INSECTOS | BENZOCAINE, ALCOHOL | M-star (Hubei) Health&Care Products Co., Ltd. | 4428774c-2a7a-4ab7-b587-ba54f16d7b93 | 2024-04-01 | Warnings | U3RSY48JW5 |
| Polyethylene Glycol 3350 | POLYETHYLENE GLYCOL 3350 | CHAIN DRUG MARKETING ASSOCIATION, INC. | 901a1918-87bb-47c2-a465-8c468c3a1ee5 | 2024-03-26 | Warnings | G2M7P15E5P |
| smoothlax | POLYETHYLENE GLYCOL 3350 | Walgreen Company | aeb5c32c-443e-4ea3-8e96-fed38225fdf3 | 2024-03-12 | Warnings | G2M7P15E5P |
| Preparation H Rapid Relief | GLYCERIN, LIDOCAINE, PETROLATUM, AND PHENYLEPHRINE HYDROCHLORIDE | Haleon US Holdings LLC | 699310e8-1a93-40b4-a8f4-a765be4a0cb1 | 2024-02-29 | Warnings | PDC6A3C0OX |
| Promescent Delay Wipes | BENZOCAINE | Absorption | f0a5b6be-acc5-473c-9054-b9534e769db1 | 2024-02-20 | Warnings | U3RSY48JW5 |
| Pain Relief | BENZOCAINE | Safetec of America, Inc. | de84e598-d047-4fae-b2ed-155a3788bc6f | 2024-02-16 | Warnings | U3RSY48JW5 |
| Benzo Jel | BENZOCAINE | Henry Schein Inc. | 2cd571fc-30ee-40da-a2c7-25adb7d4b5c3 | 2024-02-15 | Warnings | U3RSY48JW5 |
| Walgreens Boil Pain Relief | BOIL PAIN RELIEF | Walgreens Company | d11bd769-68d0-4057-bc2a-72719f16011e | 2024-02-12 | Warnings | U3RSY48JW5 |
| Antiseptic | BENZALKONIUM CHLORIDE, BENZOCAINE | Safetec of America, Inc. | 458e65f2-826d-4550-8c7d-17add2d7ba9a | 2024-02-07 | Warnings | U3RSY48JW5 |
| Topcare ClearLax | POLYETHYLENE GLYCOL 3350 | Topco Associates LLC | 02f81a86-bec5-4e8b-bddb-d463ae2ea9e9 | 2024-02-07 | Warnings | G2M7P15E5P |
| POLYETHYLENE GLYCOL 3350 | POLYETHYLENE GLYCOL 3350 | Bryant Ranch Prepack | 66276671-0ccd-4c32-a697-31e679fce0e3 | 2024-02-06 | Warnings | G2M7P15E5P |
| Polyethylene Glycol 3350 | POLYETHYLENE GLYCOL 3350 | BluePoint Laboratories | 02e36812-53c2-003b-e063-6394a90aed12 | 2024-01-31 | Warnings | G2M7P15E5P |
| No More Products | GLYCERIN, KAOLIN, CALAMINE, MENTHOL | Sarati International, Inc | 102e7dbb-06dc-f4d1-e063-6394a90aa3eb | 2024-01-26 | Warnings | PDC6A3C0OX |
| Pranicura 5 | GLYCERIN, KAOLIN, CALAMINE, MENTHOL | Sarati International, Inc. | 0fe10710-ac59-4fc5-e063-6294a90a48fc | 2024-01-26 | Warnings | PDC6A3C0OX |
| GENTEAL TEARS | DEXTRAN 70, GLYCERIN, HYPROMELLOSE | A-S Medication Solutions | a2b715e9-332d-4f0b-b8e5-ebc000681586 | 2024-01-21 | Warnings | PDC6A3C0OX |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.